SPBC337.02c Antibody

What is SPBC337.02c protein and what is known about its function in S. pombe?

SPBC337.02c is a protein found in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast . This protein is cataloged in the UniProt database with the accession number G2TRS9 . While specific functional details are not extensively documented in the provided research, it likely contributes to essential cellular processes in S. pombe given the research interest in developing antibodies against it. The protein may be involved in protein complex assembly or regulation, similar to other yeast proteins that have been extensively studied in the context of complex formation and cellular stoichiometry maintenance.

The corresponding antibody for this protein is available through commercial sources with the catalog code CSB-PA522304XA01SXV and is typically provided in either 2ml or 0.1ml aliquots . This antibody serves as an important tool for researchers investigating protein-protein interactions, complex formation, and functional analyses in fission yeast models.

How should SPBC337.02c antibody samples be prepared for optimal western blot results?

For optimal western blot results when using SPBC337.02c antibody, researchers should consider the following preparation protocol:

• Sample preparation: Extract proteins from S. pombe cells using an appropriate lysis buffer that preserves protein integrity while disrupting yeast cell walls effectively.

• Protein quantification: Use a reliable method such as Bradford assay to ensure equal loading of protein samples.

• Gel selection: Choose an appropriate percentage polyacrylamide gel based on the expected molecular weight of SPBC337.02c.

• Transfer conditions: Optimize transfer time and voltage for the SPBC337.02c protein to ensure complete transfer to the membrane.

• Blocking optimization: Test different blocking solutions (typically 3-5% BSA or non-fat milk) to minimize background without compromising specific signal.

• Antibody dilution: Determine optimal antibody concentration through dilution series testing, typically starting with 1:1000 for primary antibodies.

• Incubation parameters: Test both room temperature (1-2 hours) and 4°C overnight incubation to determine optimal binding conditions.

The choice of detection system should be based on the expected abundance of the target protein and the sensitivity requirements of your experiment. Researchers should also incorporate both positive and negative controls to validate specificity.

How can SPBC337.02c antibody be utilized in protein complex research?

SPBC337.02c antibody can be strategically employed in multiple sophisticated approaches for protein complex research:

Affinity Purification Mass Spectrometry (AP-MS): This technique, considered a gold standard for identifying protein complexes, can be implemented using SPBC337.02c antibody as the bait . The antibody is first immobilized on an appropriate matrix (such as protein A/G beads) and then incubated with cell lysate. After washing steps to remove non-specific binders, the captured protein complexes can be eluted and analyzed by mass spectrometry to identify interaction partners of SPBC337.02c . This approach is particularly powerful when implementing tandem affinity purification protocols to minimize false positives .

Cross-Linking Mass Spectrometry (XL-MS): This approach combines SPBC337.02c antibody immunoprecipitation with chemical cross-linking and subsequent mass spectrometry analysis . Cross-linkers covalently connect proteins that are in close proximity, preserving transient interactions that might be lost during conventional purification. This method provides not only information about interacting partners but also spatial constraints that can inform structural models .

Co-immunoprecipitation followed by Western blotting: When specific interaction partners are hypothesized, SPBC337.02c antibody can be used to immunoprecipitate the protein and its complexes. Western blotting with antibodies against suspected interaction partners can then confirm specific associations.

When designing these experiments, researchers should consider the assembly order of protein complexes, as adjacent genes within operons are more likely to encode physically interacting subunits . This can provide valuable context for interpreting results from SPBC337.02c interaction studies.

What considerations should be made when using SPBC337.02c antibody for super-resolution microscopy?

When employing SPBC337.02c antibody for super-resolution microscopy studies in S. pombe, researchers should address several critical factors:

Antibody validation for imaging: Before proceeding with high-resolution imaging, validate the specificity of the SPBC337.02c antibody using knockout/knockdown controls and competing peptide assays. Additionally, compare localization patterns with fluorescently tagged versions of the protein to confirm consistency.

Selection of appropriate super-resolution technique: Different super-resolution techniques offer distinct advantages:

• Stimulated emission depletion (STED) microscopy uses specialized lasers to achieve resolution beyond the diffraction limit .

• Stochastic optical reconstruction microscopy (STORM) or photoactivated localization microscopy (PALM) may provide even higher resolution for specific applications.

• Structured illumination microscopy (SIM) offers a balance of resolution enhancement with less photodamage.

Sample preparation optimization: Fission yeast cells have distinct challenges for super-resolution imaging, including:

• Cell wall treatment requirements that maintain cellular integrity while allowing antibody penetration

• Fixation protocols that preserve protein localization without introducing artifacts

• Mounting media selection that minimizes background fluorescence

Quantitative analysis approach: Develop robust analytical pipelines for:

• Measuring co-localization with other proteins of interest

• Quantifying dynamic changes in protein distribution

• Analyzing clustering patterns at high resolution

Super-resolution microscopy with SPBC337.02c antibody can reveal previously undetectable spatial relationships, potentially uncovering new insights about protein complex organization within the constrained space of yeast cells.

How might SPBC337.02c participate in ordered protein complex assembly?

Research indicates that protein complex assembly often follows specific ordered pathways that may be reflected in genomic organization . While specific details about SPBC337.02c's assembly into complexes are not directly provided in the available research, general principles about ordered assembly can inform hypotheses:

Genomic context analysis: If SPBC337.02c is encoded within an operon-like genomic structure, examining the order of genes may provide insights into its assembly position within protein complexes. Studies have demonstrated that adjacent genes within operons are more likely to encode physically interacting subunits, with a clear relationship between gene pair proximity and the likelihood of physical interaction . The gene order often closely matches the order of assembly, particularly for lowly expressed protein complexes .

Assembly position prediction: Determining whether SPBC337.02c acts as an early or late binding component in its complexes is crucial for experimental design. Early binding components typically form the core structural elements, while late binding components often serve regulatory functions. Research has shown that operon gene order is optimized for ordered assembly of protein complexes, with a significant correlation between gene order and assembly order .

Stability implications: The assembly position may influence protein stability, as proteins that assemble early into complexes often show different degradation kinetics compared to those that assemble later . Investigating the degradation rates of SPBC337.02c could provide indirect evidence about its position in the assembly hierarchy.

To experimentally determine SPBC337.02c's position in complex assembly, researchers could use pulse-chase experiments combined with immunoprecipitation at different time points, or implement reconstitution studies with purified components added in various sequences.

What approaches can be used to validate SPBC337.02c interactions identified in high-throughput studies?

High-throughput studies often generate numerous potential interaction partners for proteins like SPBC337.02c that require rigorous validation using complementary approaches:

Reciprocal co-immunoprecipitation: Following the identification of potential interaction partners through techniques like affinity purification mass spectrometry, researchers should perform reciprocal co-immunoprecipitation experiments using antibodies against the identified partners to pull down SPBC337.02c . This bidirectional validation significantly strengthens confidence in true interactions.

Proximity ligation assay (PLA): This technique can verify protein-protein interactions in situ by generating fluorescent signals only when two proteins are in very close proximity (≤40 nm). When combined with the SPBC337.02c antibody and antibodies against potential interaction partners, PLA can provide spatial information about interactions within intact cells.

FRET/BRET analysis: For particularly important interactions, researchers can implement Förster resonance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET) approaches using fluorescently tagged or luciferase-tagged versions of SPBC337.02c and its interacting partners to measure energy transfer that occurs only at molecular distances.

Protein fragment complementation assays: Split reporter systems (such as split-YFP or split-luciferase) fused to SPBC337.02c and potential partners can generate signal only when the proteins interact, bringing the reporter fragments together.

Cross-linking mass spectrometry: This technique identifies not only interaction partners but also specific residues involved in the interaction, providing structural insights . The identified cross-linked peptides can be used to map interaction interfaces at the amino acid level.

Mutational analysis: Following identification of potential binding regions, targeted mutations can be introduced to disrupt specific interactions, providing functional validation of their importance.

When designing validation experiments, researchers should consider the nature of the interaction (stable vs. transient), subcellular localization, and potential competition from endogenous proteins that might affect detection sensitivity.

What are common challenges when using SPBC337.02c antibody in immunoprecipitation and how can they be overcome?

Researchers working with SPBC337.02c antibody in immunoprecipitation experiments may encounter several challenges that require systematic troubleshooting:

Weak or no signal issues:

• Solution: Optimize lysis conditions specifically for fission yeast cells, which have robust cell walls. Consider enzymatic digestion (such as zymolyase treatment) followed by gentle mechanical disruption to ensure efficient protein extraction without denaturing epitopes.

• Solution: Test different antibody concentrations and binding conditions. Increasing antibody amount (typically 1-5 μg per reaction) or extending incubation time (overnight at 4°C) can improve capture efficiency.

• Solution: Verify antibody functionality via western blot prior to immunoprecipitation to ensure the antibody recognizes SPBC337.02c under your experimental conditions.

High background or non-specific binding:

• Solution: Implement more stringent washing protocols with increasing salt concentrations (150-500 mM NaCl) while monitoring specific signal retention.

• Solution: Pre-clear lysates with protein A/G beads before adding the SPBC337.02c antibody to remove proteins that bind non-specifically to the beads.

• Solution: Consider using tandem affinity purification approaches which significantly reduce background through sequential purification steps .

Protein complex disruption:

• Solution: Adjust lysis buffer composition to preserve native interactions by using milder detergents (0.1% NP-40 or digitonin instead of stronger detergents like SDS).

• Solution: Include stabilizing agents such as glycerol (10%) or specific protease inhibitor cocktails formulated for yeast.

• Solution: Consider in vivo cross-linking before lysis to stabilize transient or weak interactions.

Variability between experiments:

• Solution: Standardize growth conditions for S. pombe cultures, as protein expression and complex formation can vary with growth phase.

• Solution: Develop a detailed SOP (standard operating procedure) that specifies cell number, lysis volume, antibody amount, and precise timing for each step.

• Solution: Implement quantitative controls, such as spiking samples with known quantities of recombinant protein, to enable normalization between experiments.

A systematic approach to optimization, testing one variable at a time while keeping others constant, will help identify optimal conditions for SPBC337.02c immunoprecipitation.

How can researchers optimize experimental protocols to detect interactions between SPBC337.02c and lowly expressed partners?

Detecting interactions between SPBC337.02c and lowly expressed partners presents significant technical challenges that can be addressed through strategic protocol optimizations:

Starting material optimization:

• Increase the volume of yeast culture used for protein extraction. Scaling up from standard culture volumes to 1-2 liters can significantly enhance detection of low-abundance proteins.

• Consider synchronizing S. pombe cultures if the interaction is cell-cycle dependent, concentrating the population of cells in which the interaction occurs.

Enrichment strategies:

• Implement subcellular fractionation to concentrate proteins from the relevant cellular compartment where SPBC337.02c and its partners are located.

• Use sequential immunoprecipitation approaches where initial SPBC337.02c immunoprecipitate is dissociated and then subjected to another round of immunoprecipitation to further enrich specific complexes.

Enhanced detection methods:

• Employ highly sensitive mass spectrometry techniques such as Selected Reaction Monitoring (SRM) or Parallel Reaction Monitoring (PRM) that can detect proteins at attomole levels.

• Consider using isobaric labeling strategies (TMT or iTRAQ) in mass spectrometry to multiplex samples and improve quantitative accuracy for lowly abundant proteins.

• Implement western blotting with enhanced chemiluminescence substrates specifically designed for low-abundance proteins, coupled with longer exposure times or more sensitive digital imaging systems.

Protein stabilization approaches:

• Treat cells with proteasome inhibitors like MG132 (adjusted for yeast permeability) before harvesting to prevent degradation of short-lived proteins.

• Research suggests that proteins that bind late to complexes may show different degradation characteristics , so consider experiment timing carefully if targeting late-binding partners.

Expression modulation:

• Consider mild overexpression of the partner protein (while maintaining physiological relevance) to enhance detection, particularly for validation experiments.

• Use genetic approaches to stabilize lowly expressed partners, such as removing destabilizing elements or degrons if known.

Research has demonstrated that gene order matters most for lowly expressed protein complexes , suggesting evolutionary pressure for efficient assembly of complexes with low-abundance components. This principle may inform experimental design when targeting specific lowly expressed interaction partners of SPBC337.02c.

How can SPBC337.02c antibody contribute to studies of protein complex stoichiometry and assembly in S. pombe?

SPBC337.02c antibody offers powerful capabilities for investigating protein complex stoichiometry and assembly dynamics through several methodological approaches:

Quantitative immunoprecipitation studies:

• Using the SPBC337.02c antibody as a capture reagent, researchers can isolate intact protein complexes and analyze their composition through quantitative mass spectrometry .

• By implementing stable isotope labeling techniques (such as SILAC), the stoichiometric ratios of complex components can be precisely determined.

• Time-course experiments following induction or repression of complex components can reveal assembly kinetics and dependencies.

Pulse-chase analysis of complex assembly:

• SPBC337.02c antibody can be used to track newly synthesized proteins as they incorporate into complexes over time.

• This approach can reveal whether SPBC337.02c serves as an early or late binding component in its respective complexes, providing insights into assembly hierarchies .

• Comparing assembly rates under different conditions can illuminate regulatory mechanisms controlling complex formation.

Native mass spectrometry applications:

• Following immunoprecipitation with SPBC337.02c antibody, complexes can be studied by native mass spectrometry to determine intact complex mass and composition .

• This technique preserves non-covalent interactions and can reveal subcomplexes that form during assembly or disassembly.

• The approach is particularly valuable for identifying alternative complex forms or assembly intermediates.

Structural studies of complex architecture:

Understanding maintenance of cellular stoichiometry is a critical aspect of protein complex research . The SPBC337.02c antibody can contribute to these studies by enabling precise measurement of protein levels within complexes under various cellular conditions, providing insights into how cells maintain proper stoichiometric ratios despite variations in expression levels of individual components.

What are the considerations for using SPBC337.02c antibody in cross-linking mass spectrometry experiments?

Cross-linking mass spectrometry (XL-MS) represents a powerful approach for structural characterization of protein complexes that can be effectively combined with SPBC337.02c antibody-based purification . Researchers should consider the following critical factors:

Cross-linker selection considerations:

• Choose cross-linkers based on spacer arm length: shorter cross-linkers (e.g., DSS, BS3 with ~11.4Å spacer arms) provide higher-resolution distance constraints but may capture fewer interactions.

• Consider reactivity chemistry: While lysine-reactive cross-linkers (NHS esters) are most common, combining them with cross-linkers targeting other residues (like carboxyls, cysteines) can provide complementary structural information.

• Evaluate membrane permeability for in vivo cross-linking applications: cell-permeable cross-linkers allow capturing interactions in their native cellular environment.

• Assess cleavability: MS-cleavable cross-linkers (like DSSO or DSBU) simplify data analysis by generating characteristic fragmentation patterns.

Experimental workflow optimization:

• For in vivo approaches, determine optimal cross-linker concentration and reaction time through pilot experiments to maximize specific cross-links while minimizing non-specific aggregation.

• For in vitro approaches following SPBC337.02c immunoprecipitation, carefully control protein concentration to favor intramolecular and specific intermolecular cross-links.

• Consider stepwise cross-linking with differentially labeled cross-linkers to determine assembly order.

Sample processing requirements:

• Implement specialized digestion protocols that account for the altered protease accessibility of cross-linked proteins.

• Consider using multiple proteases beyond trypsin (such as chymotrypsin, AspN, or GluC) to increase cross-link identification coverage.

• Apply SEC or SCX fractionation to enrich for cross-linked peptides, which typically represent a small fraction of the total peptide pool.

Data analysis challenges:

• Select appropriate cross-link search algorithms that can handle the combinatorial complexity of XL-MS data.

• Implement stringent false discovery rate controls, typically using a target-decoy approach specifically designed for cross-linking applications.

• Validate identified cross-links through comparison with known structural data or through independent experimental approaches.

The integration of cross-linking data with other structural biology techniques provides especially powerful insights . Researchers can combine SPBC337.02c antibody-based XL-MS with computational modeling approaches to generate or refine structural models of protein complexes containing this protein .

What emerging technologies might enhance SPBC337.02c research in the future?

Several cutting-edge technologies are poised to revolutionize research involving SPBC337.02c antibody, offering unprecedented insights into protein function and interactions:

Cryo-electron tomography applications:

• This technology extends beyond traditional cryo-EM by enabling 3D visualization of macromolecular complexes directly within cellular contexts .

• For SPBC337.02c research, this could reveal not just protein complex structure but also cellular localization and contextual interactions.

• Combining with immunogold labeling using SPBC337.02c antibody could specifically identify this protein within the cellular milieu.

Integrative structural biology approaches:

• Combining multiple techniques (XL-MS, cryo-EM, crystallography, NMR) with computational modeling to generate comprehensive structural models .

• This multi-method approach could overcome limitations of individual techniques when studying SPBC337.02c-containing complexes.

• Particular value comes from integrating interaction data from antibody-based studies with structural information.

Proximity labeling technologies:

• Techniques like BioID or APEX2 could be fused to SPBC337.02c to map its proximal protein environment in living cells.

• This would complement traditional antibody-based immunoprecipitation by capturing both stable and transient interactions.

• Temporal control of labeling could reveal dynamic changes in SPBC337.02c associations during cellular processes.

Single-molecule approaches:

• Single-molecule FRET or optical tweezers combined with SPBC337.02c antibody detection could reveal dynamic conformational changes during complex assembly or function.

• These techniques offer insights into reaction kinetics and rare states that are typically masked in bulk measurements.

AI/ML for structural prediction:

• Leveraging advances in protein structure prediction (like AlphaFold) to model SPBC337.02c interactions .

• This could be particularly valuable for generating hypotheses about regions involved in protein-protein interactions that can then be tested experimentally with the antibody.

These emerging technologies, when combined with traditional antibody-based approaches, promise to provide unprecedented insights into SPBC337.02c function within the complex cellular environment of S. pombe. The integration of structural, functional, and temporal data will be key to developing a comprehensive understanding of this protein's role in cellular processes.

What controls and validation steps are essential when using SPBC337.02c antibody in research?

Rigorous control and validation procedures are essential for generating reliable and reproducible results with SPBC337.02c antibody:

Antibody specificity validation:

• Western blot analysis: Perform western blotting on wild-type S. pombe lysate alongside a knockout or knockdown strain (if available) to confirm specific binding to SPBC337.02c.

• Peptide competition assay: Pre-incubate the antibody with excess of the immunizing peptide before use in applications to demonstrate that signal disappearance confirms specificity.

• Immunoprecipitation-mass spectrometry: Analyze the proteins pulled down by the antibody to confirm enrichment of SPBC337.02c and expected interaction partners.

• Immunofluorescence comparison: Compare localization patterns obtained with the antibody to GFP-tagged SPBC337.02c expressed from its endogenous locus.

Experimental controls:

• Negative controls: Include isotype-matched irrelevant antibodies in parallel experiments to identify non-specific binding or background issues.

• Input controls: Always analyze a portion of the pre-immunoprecipitation sample to confirm presence of target proteins and enable quantitative assessment of enrichment.

• Loading controls: Use well-established housekeeping proteins appropriate for S. pombe when performing quantitative western blot analysis.

• Cross-reactivity testing: Validate the antibody against related proteins, particularly those with high sequence homology in S. pombe.

Reproducibility considerations:

• Antibody lot testing: Validate each new lot of SPBC337.02c antibody against previous lots to ensure consistent performance.

• Protocol standardization: Establish detailed protocols with precisely defined parameters (antibody dilutions, incubation times, buffer compositions) to ensure reproducibility.

• Biological replicates: Perform experiments with at least three biological replicates derived from independent S. pombe cultures.

• Technical replicates: Include multiple technical replicates, particularly for quantitative applications, to assess methodological variability.

Application-specific validations:

• For mass spectrometry: Implement appropriate statistical methods to distinguish true interactors from contaminants, considering resources like the CRAPome database.

• For immunofluorescence: Include peptide competition controls alongside primary antibody omission controls.

• For chromatin immunoprecipitation: If applicable, validate with tagged protein approaches in parallel.

Researchers should document all validation steps and include them in publications to enable proper evaluation of results and facilitate reproducibility by others in the field.

What is the relationship between protein complex assembly and protein degradation kinetics for proteins like SPBC337.02c?

The relationship between protein complex assembly and degradation kinetics represents a fundamental aspect of cellular protein homeostasis that has significant implications for studying proteins like SPBC337.02c:

Protection through complex incorporation:
Research indicates that incorporation into complexes often protects proteins from degradation . When studying SPBC337.02c, researchers should consider that its degradation rate may be significantly influenced by its assembly status. Unassembled or excess SPBC337.02c that cannot incorporate into complexes might show accelerated degradation, while complex-incorporated protein would demonstrate extended half-life. This phenomenon has important implications for interpreting turnover studies and understanding cellular regulation of SPBC337.02c levels.

Assembly order effects on stability:
Studies have shown that a protein's position in the assembly hierarchy of a complex can significantly impact its degradation kinetics . Early-assembling components often show different degradation patterns compared to late-binding components. If SPBC337.02c is an early-assembling component, it may show degradation patterns distinct from late-binding partners. This relationship can be leveraged to indirectly determine SPBC337.02c's position in assembly pathways by comparing its degradation kinetics with those of known early and late-assembling components.

Methodological implications:
When designing experiments to measure SPBC337.02c levels or turnover, researchers should consider:

• Using methods that can distinguish between free and complex-incorporated forms of the protein

• Implementing pulse-chase experiments to track newly synthesized SPBC337.02c as it incorporates into complexes

• Comparing degradation rates under conditions that promote or inhibit complex formation

Regulatory mechanisms:
The cell employs sophisticated mechanisms to ensure proper stoichiometry of complex components . These may include:

• Selective degradation of excess unassembled subunits through quality control mechanisms

• Translational regulation coordinated with assembly status

• Feedback mechanisms where complex assembly influences production rates

Experimental approaches:
To investigate these relationships for SPBC337.02c specifically, researchers might:

• Compare degradation rates of SPBC337.02c in wild-type cells versus cells depleted of known complex partners

• Measure degradation kinetics of SPBC337.02c variants with mutations that disrupt specific protein-protein interactions

• Track SPBC337.02c levels during cellular transitions that affect complex formation

Understanding the interplay between SPBC337.02c complex assembly and degradation provides important insights into cellular mechanisms that maintain proper stoichiometry and function of protein complexes containing this protein.